Advertisement

Topics

Companies Related to "Antibiotic stewardship teams must planned paid halt dangerous" [Most Relevant Company Matches] RSS

19:45 EDT 23rd September 2017 | BioPortfolio

Here are the most relevant search results for "Antibiotic stewardship teams must planned paid halt dangerous" found in our extensive corporate database of over 50,000 company records.

Showing "Antibiotic stewardship teams must planned paid halt dangerous" Companies 1–25 of 736

Thursday 14th September 2017

KalVista Pharmaceuticals, Inc.

KalVista Pharmaceuticals, Inc. is a pharmaceuticals company focused on the discovery, development, and commercialization of small molecule protease inhibitors for diseases with significant unmet need. The initial focus is on inhibitors of plasma kallikrein, which is an important component of the body’s inflammatory response and which, in excess, can l...


Wednesday 13th September 2017

ICONIC Protein

ICONIC Protein is one of the fastest-growing brands in the ready-to-drink protein beverage market with a passionate following of health-conscious consumers who have flocked to the brand’s healthy and great-tasting options. Made using dairy protein from grass-fed cows in New Zealand, ICONIC’s ready-to-drink beverage line is hormone, antibiotic and...

Wednesday 6th September 2017

PlayMaker

PlayMaker is the leading sales platform for post-acute care. Our solution combines industry-specific referral management tools with EHR referral history and actionable market data to empower sales teams and executives to achieve their growth goals.


MedAptus Corporation

MedAptus is a Boston-based healthcare technology company that helps care teams work better together by providing patient assignment, secure communications and charge capture software. The company’s solutions have boosted financial performance, improved operations, and enhanced team care coordination for hospitals and other healthcare organizations thr...

Tuesday 5th September 2017

Formstack

Formstack is a versatile online form solution that streamlines processes for capturing and managing information. With Formstack, businesses and teams of all types and sizes can easily create and use online forms to automate repetitive business processes and gain rich insights. People can embed forms directly onto their websites and social media profiles to...

Monday 28th August 2017

EUSA Pharma

EUSA Pharma is a rapidly growing transatlantic specialty pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, pain control and critical care products. The company currently has eight marketed products, including Caphosol(R) for the treatment of oral mucositis, a common and debilitating side-effect of radiation therapy and high dose chemotherapy, Erwinas...

Thursday 24th August 2017

labfolder

labfolder builds a well-designed productivity platform for research teams, supporting scientists in their quest to make groundbreaking discoveries.

Wednesday 23rd August 2017

Trial By Fire Solutions

Trial By Fire Solutions is a global leader in web-based clinical trial management solutions and develops innovative applications to improve planning, execution and tracking of clinical studies. Since the release of its SimpleCTMS product, Trial By Fire Solutions has been providing affordable eClinical solutions to teams of all sizes.

Tuesday 22nd August 2017

Vestar Capital Partners V, L.P.

Vestar Capital Partners is a leading global private equity firm with more than 22 years of experience investing in middle-market companies with $7 billion in assets currently under management. From its headquarters in New York, and through its five offices in the U.S. and Europe, Vestar employs its value-oriented investment approach across a variety of ...

Tuesday 15th August 2017

Allegory Press LLC

Allego’s sales learning platform boosts sales performance by harnessing the power of mobile to transform enablement and training through video content sharing. With Allego’s mobile-first platform, organizations can create and curate the best content from the field and corporate office to better train and collaborate with distributed sales teams, without...

Thursday 10th August 2017

Symbiomix Therapeutics, LLC

Symbiomix (sim-bye-OH-mix) is a biopharmaceutical company bringing innovative medicines to market for prevalent gynecological infections that can have serious health consequences. The Company’s lead investigational drug Solosec™ (secnidazole) oral granules, a potent, next-generation 5-nitroimidazole antibiotic, is anticipated to be the first and ...

Sverica Capital Management LLC

Sverica is a leading private equity firm that has raised over $500 million of investment capital across multiple funds. The firm seeks to invest in companies that are or could become leaders in their industries, and works closely with the management of such companies to facilitate their growth. Since 2001, Sverica has maintained a “high touch” op...

Wednesday 2nd August 2017

AgeX Therapeutics, Inc.

AgeX Therapeutics, Inc., a subsidiary of BioTime, Inc. (NYSE MKT:BTX), is a biotechnology company applying technology relating to cell immortality and regenerative biology, to aging and age-related diseases. The company has three initial areas of product development: pluripotent stem cell-derived brown adipocytes (AGEX-BAT1); vascular progenitors (AGEX-VAS...

Shore Capital Partners

Shore Capital is a Chicago-based private equity firm focused exclusively on microcap healthcare investments. Shore supports management partners with capital, business development expertise, and industry knowledge to accelerate growth, fund acquisitions, and generate value to shareholders. Shore targets investments in proven, successful private companies wi...

Tuesday 1st August 2017

Laminate Medical Technologies

Laminate Medical Technologies was founded in 2012 by Tammy Gilon and Dr. Eyal Orion, who began their work in the Rad-Biomed incubator. Laminate has developed VasQ, a blood vessel support device for patients receiving dialysis. VasQ is CE Marked and used in hospitals in Europe and Israel. Clinical trials for approval by the U.S. Food and Drug Administration ...

Tuesday 25th July 2017

VenatoRx Pharmaceuticals, Inc.

VenatoRx Pharmaceuticals is a private pharmaceutical company dedicated to the discovery and development of novel agents to address the threat of antibiotic bacteria resistance. Its lead clinical program combines VNRX-5133, a novel β-lactamase inhibitor, with an approved and marketed β-lactam antibiotic. This press release contains “forward-looking ...

Thursday 13th July 2017

Moving Mountains for Multiple Myeloma

Moving Mountains for Multiple Myeloma is supported by the MMRF, CURE Media Group and Takeda. In addition to the Mt. Fuji 2017 climb, Moving Mountains for Multiple Myeloma treks planned for 2018 include a trip to Everest Base Camp in March. Funds raised by the Moving Mountains for Multiple Myeloma endeavors will go directly to research, supporting the MMRF ...

Thursday 29th June 2017

Synspira

Synspira is developing a new class of inhalable glycopolymer-based therapeutics that disrupt mucus accumulation and biofilm invasion, which are key drivers of pulmonary diseases including cystic fibrosis (CF), chronic obstructive pulmonary disease (COPD), and pneumonia. Synspira has an exclusive license from Synedgen to the Glycomics Technology Platform fo...

Wednesday 21st June 2017

Outcome Capital, LLC

Outcome Capital is a unique investment banking firm that provides middle-market growth companies in the life sciences, health care services and technology markets with a value-added client-centric approach to merger, acquisition and corporate finance advisory services. The firm utilizes its proven approach to value enhancement by assisting boards and manag...

Monday 12th June 2017

Cigna Corporation and Dallas Wings

The Dallas Wings are one of twelve professional teams in the Women’s National Basketball Association (WNBA). The team was founded in Detroit, Michigan in 1998 as the Detroit Shock. After 12 years and three championships (2003, 2006 and 2008), the team moved to Tulsa, where they were known as the Tulsa Shock. In 2016, the team played their first season...

Tuesday 2nd May 2017

Medicortex Finland Oy

Medicortex Finland Oy (http://www.medicortex.fi) is a biotechnology company dedicated to improving the diagnostics and treatment of Traumatic Brain Injury (TBI). Is currently developing biomarker diagnostics that evaluate the extent and severity of TBI. Once the company completes this test its next goal will be to develop an innovative drug to halt the pro...

Thursday 27th April 2017

Amazentis SA

Amazentis SA is a life science company that employs today’s leading research and clinical science to develop the next generation of bioactive ingredients derived from nature for advanced therapeutic nutrition products. The Company’s lead product candidate, AMAZ-02, an oral formulation of Urolithin A, is planned to enter Phase 2 clinical testing d...

Wednesday 26th April 2017

Medicortex

Medicortex Finland Oy (http://www.medicortex.fi) is a biotechnology company dedicated to improving the diagnostics and treatment of Traumatic Brain Injury (TBI). Its current focus is to develop biomarker diagnostics that evaluate the extent and severity of TBI. Once the company completes this test its next goal will be to develop an innovative drug to halt...

Thursday 20th April 2017

NAEJA-RGM Pharmaceuticals Inc.

NAEJA-RGM Pharmaceuticals Inc. is a global, early-stage drug discovery company with a promising new antibiotic project currently in preclinical development. NAEJA-RGM has other projects in various stages of development as well as a compound library developed over many years by Dr. Ronald G. Micetich’s drug discovery team. The headquarters and laborato...

Tuesday 11th April 2017

Appili Therapeutics Inc.

Appili is dedicated to identifying, acquiring and advancing novel therapeutics for infectious disease. The company has two anti-infective programs, ATI-1501 and ATI-1503, in its pipeline. ATI-1501 is a taste-masked treatment for anaerobic infections, including C. difficile. Appili’s second product, ATI-1503, is a novel antibiotic with broad potential ...


More From BioPortfolio on "Antibiotic stewardship teams must planned paid halt dangerous"

Quick Search
Advertisement
 

Corporate Database Quicklinks